1. Recent advances in pharmacological research on Ecklonia species: a review
- Author
-
Prashamsa Koirala, Jae Sue Choi, and Hyun Ah Jung
- Subjects
0301 basic medicine ,Pharmacological research ,Review ,Biology ,Health benefits ,Phaeophyta ,03 medical and health sciences ,0302 clinical medicine ,Japan ,Drug Discovery ,Botany ,Republic of Korea ,Animals ,Humans ,Brown seaweed ,Medicine, East Asian Traditional ,Biological Products ,Traditional medicine ,Organic Chemistry ,Ecklonia ,biology.organism_classification ,Antimicrobial ,Brown algae ,030104 developmental biology ,Lessoniaceae ,Phytochemical ,030220 oncology & carcinogenesis ,Molecular Medicine ,Dietary fiber ,Therapeutic potential - Abstract
The genus Ecklonia (Lessoniaceae, Phaeophyceae), commonly called kelp (brown algae), is abundant on the coasts of Japan and Korea. During the past few decades, Ecklonia species have received tremendous attention for their wide range of therapeutic properties and multiple health benefits, such as great nutritional value and being rich in vitamins, minerals, dietary fiber, proteins, and polysaccharides. Several novel functional ingredients with diversified biological activities have been isolated and possess antimicrobial, antiviral, hepatoprotective, cardioprotective, anti-inflammatory, neuroprotective, anticarcinogenic, immunomodulatory, hypolipidemic, anti-diabetic, and antioxidant therapeutic properties. The present review discusses the phytochemical, pharmacological, therapeutic, nutritional, and health benefits of different species of genus Ecklonia, as well as their use in the prevention of disease and maintenance of good health.
- Published
- 2017